Cargando…

Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?

INTRODUCTION: The Community Outreach and Patient Empowerment (COPE) intervention provides integrated outreach through community health representatives (CHRs) to people living with diabetes in Navajo Nation. The aim of this study was to identify groups for whom the intervention had the greatest effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Trevisi, Letizia, Orav, John E., Atwood, Sidney, Brown, Christian, Curley, Cameron, King, Caroline, Muskett, Olivia, Sehn, Hannah, Nelson, Adrianne Katrina, Begay, Mae-Gilene, Shin, Sonya S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380292/
https://www.ncbi.nlm.nih.gov/pubmed/32701432
http://dx.doi.org/10.5888/pcd17.200068
_version_ 1783562824733163520
author Trevisi, Letizia
Orav, John E.
Atwood, Sidney
Brown, Christian
Curley, Cameron
King, Caroline
Muskett, Olivia
Sehn, Hannah
Nelson, Adrianne Katrina
Begay, Mae-Gilene
Shin, Sonya S.
author_facet Trevisi, Letizia
Orav, John E.
Atwood, Sidney
Brown, Christian
Curley, Cameron
King, Caroline
Muskett, Olivia
Sehn, Hannah
Nelson, Adrianne Katrina
Begay, Mae-Gilene
Shin, Sonya S.
author_sort Trevisi, Letizia
collection PubMed
description INTRODUCTION: The Community Outreach and Patient Empowerment (COPE) intervention provides integrated outreach through community health representatives (CHRs) to people living with diabetes in Navajo Nation. The aim of this study was to identify groups for whom the intervention had the greatest effect on glycated hemoglobin A(1c) (HbA(1c)). METHODS: We analyzed de-identified data extracted from routine health records dated from December 1, 2010, through August 31, 2014, to compare net change in HbA(1c) among COPE patients and non-COPE patients. We used linear mixed models to assess whether the intervention was modified by age, sex, preferred language, having a primary care provider, baseline HbA(1c), or having a mental health condition. RESULTS: Age, having a primary care provider, and baseline HbA(1c) significantly modified HbA(1c) levels. Among patients aged 64 or younger, COPE participation was associated with a net decrease in HbA(1c) of 0.77%; among patients aged 65 or older, the net decrease was 0.49% (P = .03). COPE participation was associated with a steeper decrease in HbA(1c) among patients without a primary care physician (net decrease, 0.99%) than among patients with a primary care provider (net decrease, 0.57%) (P = .03). COPE patients with a baseline HbA(1c) >9% had a net decrease of 0.70%, while those with a baseline HbA(1c) ≤9% had a net decrease of 0.34% (P = .01). We found no significant differences based on sex, preferred language, or having a mental health condition. CONCLUSION: Findings suggest that the COPE intervention was robust and equitable, benefiting all groups living with diabetes in Navajo Nation, but conferring the greatest benefit on the most vulnerable.
format Online
Article
Text
id pubmed-7380292
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-73802922020-08-04 Community Outreach for Navajo People Living with Diabetes: Who Benefits Most? Trevisi, Letizia Orav, John E. Atwood, Sidney Brown, Christian Curley, Cameron King, Caroline Muskett, Olivia Sehn, Hannah Nelson, Adrianne Katrina Begay, Mae-Gilene Shin, Sonya S. Prev Chronic Dis Original Research INTRODUCTION: The Community Outreach and Patient Empowerment (COPE) intervention provides integrated outreach through community health representatives (CHRs) to people living with diabetes in Navajo Nation. The aim of this study was to identify groups for whom the intervention had the greatest effect on glycated hemoglobin A(1c) (HbA(1c)). METHODS: We analyzed de-identified data extracted from routine health records dated from December 1, 2010, through August 31, 2014, to compare net change in HbA(1c) among COPE patients and non-COPE patients. We used linear mixed models to assess whether the intervention was modified by age, sex, preferred language, having a primary care provider, baseline HbA(1c), or having a mental health condition. RESULTS: Age, having a primary care provider, and baseline HbA(1c) significantly modified HbA(1c) levels. Among patients aged 64 or younger, COPE participation was associated with a net decrease in HbA(1c) of 0.77%; among patients aged 65 or older, the net decrease was 0.49% (P = .03). COPE participation was associated with a steeper decrease in HbA(1c) among patients without a primary care physician (net decrease, 0.99%) than among patients with a primary care provider (net decrease, 0.57%) (P = .03). COPE patients with a baseline HbA(1c) >9% had a net decrease of 0.70%, while those with a baseline HbA(1c) ≤9% had a net decrease of 0.34% (P = .01). We found no significant differences based on sex, preferred language, or having a mental health condition. CONCLUSION: Findings suggest that the COPE intervention was robust and equitable, benefiting all groups living with diabetes in Navajo Nation, but conferring the greatest benefit on the most vulnerable. Centers for Disease Control and Prevention 2020-07-23 /pmc/articles/PMC7380292/ /pubmed/32701432 http://dx.doi.org/10.5888/pcd17.200068 Text en https://creativecommons.org/licenses/by/4.0/Preventing Chronic Disease is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Original Research
Trevisi, Letizia
Orav, John E.
Atwood, Sidney
Brown, Christian
Curley, Cameron
King, Caroline
Muskett, Olivia
Sehn, Hannah
Nelson, Adrianne Katrina
Begay, Mae-Gilene
Shin, Sonya S.
Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?
title Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?
title_full Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?
title_fullStr Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?
title_full_unstemmed Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?
title_short Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?
title_sort community outreach for navajo people living with diabetes: who benefits most?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380292/
https://www.ncbi.nlm.nih.gov/pubmed/32701432
http://dx.doi.org/10.5888/pcd17.200068
work_keys_str_mv AT trevisiletizia communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT oravjohne communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT atwoodsidney communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT brownchristian communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT curleycameron communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT kingcaroline communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT muskettolivia communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT sehnhannah communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT nelsonadriannekatrina communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT begaymaegilene communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost
AT shinsonyas communityoutreachfornavajopeoplelivingwithdiabeteswhobenefitsmost